Literature DB >> 2664236

Progress in medical defense against nerve agents.

M A Dunn1, F R Sidell.   

Abstract

For nearly 50 years, nerve agents have constituted a serious threat that has stimulated extensive efforts to develop effective medical countermeasures. Recent progress in producing pharmacologic defenses suggests that humans can be largely protected from the lethal and prolonged incapacitating effects of these compounds on a chemical battlefield. Current research on new approaches to binding and inactivating nerve agents may further decrease their potential as a threat against protected persons.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2664236

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  22 in total

1.  Overcoming inhibitions.

Authors:  Kenneth J Kellar
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

2.  In vitro evaluation of the catalytic activity of paraoxonases and phosphotriesterases predicts the enzyme circulatory levels required for in vivo protection against organophosphate intoxications.

Authors:  Yacov Ashani; Haim Leader; Nidhi Aggarwal; Israel Silman; Franz Worek; Joel L Sussman; Moshe Goldsmith
Journal:  Chem Biol Interact       Date:  2016-05-06       Impact factor: 5.192

3.  Sarin poisoning of a rescue team in the Matsumoto sarin incident in Japan.

Authors:  T Nakajima; S Sato; H Morita; N Yanagisawa
Journal:  Occup Environ Med       Date:  1997-10       Impact factor: 4.402

4.  Bioscavenger for protection from toxicity of organophosphorus compounds.

Authors:  Ashima Saxena; Wei Sun; Chunyuan Luo; Todd M Myers; Irwin Koplovitz; David E Lenz; Bhupendra P Doctor
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 5.  Acetylcholinesterase inhibition resulting from exposure to inhaled OP can be prevented by pretreatment with BChE in both macaques and minipigs.

Authors:  Yvonne Rosenberg; Ashima Saxena
Journal:  Neuropharmacology       Date:  2020-05-19       Impact factor: 5.250

6.  MHP-133, a drug with multiple CNS targets: potential for neuroprotection and enhanced cognition.

Authors:  Jerry J Buccafusco; James C Powers; Maria A Hernandez; Mark A Prendergast; Alvin V Terry; Ramamohana R Jonnala
Journal:  Neurochem Res       Date:  2007-04-03       Impact factor: 3.996

7.  Human carboxylesterase 1 stereoselectively binds the nerve agent cyclosarin and spontaneously hydrolyzes the nerve agent sarin.

Authors:  Andrew C Hemmert; Tamara C Otto; Monika Wierdl; Carol C Edwards; Christopher D Fleming; Mary MacDonald; John R Cashman; Philip M Potter; Douglas M Cerasoli; Matthew R Redinbo
Journal:  Mol Pharmacol       Date:  2010-01-05       Impact factor: 4.436

8.  Oral Pretreatment with Galantamine Effectively Mitigates the Acute Toxicity of a Supralethal Dose of Soman in Cynomolgus Monkeys Posttreated with Conventional Antidotes.

Authors:  Malcolm Lane; D'Arice Carter; Joseph D Pescrille; Yasco Aracava; William P Fawcett; G William Basinger; Edna F R Pereira; Edson X Albuquerque
Journal:  J Pharmacol Exp Ther       Date:  2020-08-05       Impact factor: 4.030

9.  Effect of pyridostigmine on the exercise-heat response of man.

Authors:  Y Epstein; R Arnon; D Moran; D S Seidman; Y Danon
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1990

10.  Comparison of several oximes on reactivation of soman-inhibited blood, brain and tissue cholinesterase activity in rats.

Authors:  T M Shih
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.